Discover the full management transaction log of CareCloud, Inc., a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, CareCloud, Inc. has recorded 51 insider filings. The latest transaction was disclosed on 30 June 2022 — Cession. Among the most active insiders: DALY JOHN N. All data is accessible without an account.
FY ended December 2025 · cache
25 of 51 declarations
CareCloud, Inc. is a U.S.-based healthcare technology company listed on the NASDAQ under the ticker CCLD, with corporate headquarters in Somerset, New Jersey, United States. For French-speaking investors, CareCloud should be viewed as a vertical software-and-services provider serving medical practices, physician groups, and healthcare organizations across the U.S. The company was founded in 1999 under the name Medical Transcription Billing, Corp. and has since evolved into a more integrated healthcare IT platform, ultimately adopting the CareCloud name as it expanded its product set and repositioned toward cloud-based healthcare workflow automation. Its business model combines proprietary software, recurring SaaS-style services, and outsourced operational support, which can provide a diversified revenue base but also exposes the company to competitive pressure and execution risk. CareCloud’s core offerings include revenue cycle management (RCM), electronic health records (EHR), practice management, patient engagement, healthcare analytics, digital health services, and IT professional services and staffing. In recent periods, the company has also highlighted AI-enabled products and workflows, reflecting a broader industry push to automate administrative tasks, improve documentation, and enhance productivity for providers facing reimbursement complexity and staffing constraints. This AI emphasis is strategically important because it helps CareCloud differentiate itself in a crowded market where national EHR vendors, revenue-cycle specialists, and integrated healthcare platforms compete for the same provider budgets. Geographically, CareCloud is primarily focused on the United States and serves a nationwide client base, with a particular orientation toward ambulatory practices and multi-specialty medical organizations. Recent developments have centered on product expansion, AI initiatives, targeted acquisitions, and capital structure simplification. In 2025, the company accelerated its acquisition strategy to broaden its footprint in adjacent healthcare services, while in 2026 it continued to communicate operational improvements, new product introductions, and steps to streamline its balance sheet and preferred capital structure. That combination suggests a company trying to deepen its platform economics while strengthening financial flexibility. From an equity perspective, CareCloud is a niche U.S. healthcare IT name on NASDAQ with exposure to long-term secular demand for digital healthcare infrastructure, but it remains sensitive to customer retention, integration of acquisitions, pricing pressure, and the pace at which its AI-led initiatives translate into durable margin improvement and growth.